Urine Metabolite Test Shows Potential for Autism Risk Screening
The screening tool identifies specific molecules produced by gut bacteria to distinguish children with autism from typically developing peers.
The screening tool identifies specific molecules produced by gut bacteria to distinguish children with autism from typically developing peers.
TOBY, Inc. has completed its participation in the prestigious Mayo Clinic and Arizona State University MedTech Accelerator.
A new study validated a urine test that offers a less invasive, more accurate alternative to traditional prostate cancer screening.
A novel biosensor detects SDMA in urine, providing a more accurate, non-invasive method for early kidney disease diagnosis and monitoring.
Read MoreBiotia’s BIOTIA-ID Urine NGS Assay uses artificial intelligence (AI) and genomics to deliver rapid, highly accurate UTI diagnoses.
Read MoreResearchers are exploring urine analysis as a tool for early detection of diseases by studying RNA and other substances in urine.
Read MoreCarolina Liquid Chemistries and Medline partnered to distribute a urine test kit that enhances access to rapid fentanyl screening.
Read MoreIntelligent Bio Solutions completed biocompatibility testing for its fingerprint drug screening system, advancing toward 510(k) clearance.
Read MoreSarstedt has been selected to exhibit its Needle-Free Transfer (NFT) Urine Collection System at the Vizient Innovative Technology Exchange.
Read MoreResearchers have developed a novel metasurface biosensor platform that improves the detection and monitoring of chronic kidney disease.
Read MoreLuxor Scientific has developed advanced testing solutions to address the nation’s ongoing overdose crises.
Read MoreThe CLP March/April 2024 Tech Guide in Clinical Lab Products (CLP) showcases a diverse array of products from seven laboratory providers.
Read MoreGeorge Mason University researchers have been awarded over $1 million to develop a urine-based Lyme disease test.
Read MoreA new study collected data on drug use by swabbing smartphone surfaces and analyzing residues. There are limitations to the method, however.
Read MoreResearchers developed a urine-based test utilizing whole genome sequencing to detect DNA fragments released by head and neck tumors.
Read MoreQuidelOrtho added the immunoassay for the qualitative detection of fentanyl to its Vitros systems to address the need for opioid testing.
Read MoreNanostics announced an agreement with Alberta Health Services to help drive diagnostic and prognostic innovations in urological care.
Read MoreThe new drug screening technique can rapidly detect the presence of 40 forensically relevant drugs from urine samples.
Read More